# Mylotarg and Ara-C in Untreated Patients Above 60 Years With AML and High-Risk MDS

> **NCT00195000** · PHASE2 · COMPLETED · sponsor: **Weill Medical College of Cornell University** · enrollment: 43 (actual)

## Conditions studied

- Acute Myeloid Leukemia
- Myelodysplastic Syndrome

## Interventions

- **DRUG:** Mylotarg
- **DRUG:** Cytarabine

## Key facts

- **NCT ID:** NCT00195000
- **Lead sponsor:** Weill Medical College of Cornell University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-05
- **Primary completion:** 2006-05
- **Final completion:** 2008-02
- **Target enrollment:** 43 (ACTUAL)
- **Last updated:** 2013-06-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00195000

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00195000, "Mylotarg and Ara-C in Untreated Patients Above 60 Years With AML and High-Risk MDS". Retrieved via AI Analytics 2026-08-11 from https://api.ai-analytics.org/clinical/NCT00195000. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*